Form 4: Neuronetics Director Cucuz Increases Stake with $200,000 Stock Purchase

Director Sasha Cucuz recently purchased 88,888 shares of Neuronetics, Inc. common stock at $2.25 per share, increasing their total holdings.

Summary

• On February 7, 2025, Sasha Cucuz, a director of Neuronetics, Inc., acquired 88,888 shares of common stock at a price of $2.25 per share.
• This purchase was made in connection with a firm commitment underwritten offering.
• Following the transaction, Cucuz directly owns 1,476,388 shares of Neuronetics common stock.
• Cucuz also has indirect beneficial ownership through Greybrook Realty Partners Inc. (2,042 shares) and Greybrook Health Inc. (516,084 shares), but disclaims beneficial ownership except to the extent of his pecuniary interest.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but it's a single transaction and doesn't provide a comprehensive view of the company's overall health.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider transactions are closely watched by investors as they can provide insights into management's perspective on the company's valuation and future performance. A purchase by a director is generally viewed more favorably than a sale.

Stakeholder Impact

• Shareholders may view the director's purchase as a positive signal.
• The purchase has a minimal impact on other stakeholders.

Key Dates